abdul basit

Dr. abdul basit

School of Biology, University of St Andrews, St Andrews, UK
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TATanveer Ali
Tanveer Ali
ABabdul basit
abdul basit
Asad Mustafa KarimAsad Mustafa Karim
Asad Mustafa Karim
JLJung Hun Lee
Jung Hun Lee
JJJeong-Ho Jeon
Jeong-Ho Jeon
SLSang Hee Lee
Sang Hee Lee
β-Lactam antibiotics target penicillin-binding proteins and inhibit the synthesis of peptidoglycan, a crucial step in cell wall biosynthesis. Staphylococcus aureus acquires resistance against β-lactam antibiotics by producing a penicillin-binding protein 2a (PBP2a), encoded by the mecA gene. PBP2a participates in peptidoglycan biosynthesis and exhibits a poor affinity towards β-lactam antibiotics. The current study was performed to determine the diversity and the role of missense mutations of PBP2a in the antibiotic resistance mechanism. The methicillin-resistant Staphylococcus aureus (MRSA) isolates from clinical samples were identified using phenotypic and genotypic techniques. The highest frequency (60%, 18 out of 30) of MRSA was observed in wound specimens. Sequence variation analysis of the mecA gene showed four amino acid substitutions (i.e., E239K, E239R, G246E, and E447K). The E239R mutation was found to be novel. The protein-ligand docking results showed that the E239R mutation in the allosteric site of PBP2a induces conformational changes in the active site and, thus, hinders its interaction with cefoxitin. Therefore, the present report indicates that mutation in the allosteric site of PBP2a provides a more closed active site conformation than wide-type PBP2a and then causes the high-level resistance to cefoxitin.
1



1 February 2022 in Anaerobe
Verified
Journal Article
Closed access
ZHZulquernain Haider
Zulquernain Haider
TATanveer Ali
Tanveer Ali
AUAsim Ullah
Asim Ullah
ABabdul basit
abdul basit
Hamza TahirHamza Tahir
Hamza Tahir
SRShafiq ur Rehman
Shafiq ur Rehman
1

1 December 2019 in Journal of Biotechnology
Verified
Journal Article
Closed access
ABabdul basit
abdul basit
RTRazia Tajwar
Razia Tajwar
SSSaima Sadaf
Saima Sadaf
Yang ZhangYang Zhang
Yang Zhang
MAMuhammad Akhtar
Muhammad Akhtar
1

1 December 2018 in Biotechnology Reports
Verified
Journal Article
Open access
ABabdul basit
abdul basit
FAFaiza Asghar
Faiza Asghar
SSSaima Sadaf
Saima Sadaf
MAMuhammad Akhtar
Muhammad Akhtar
Hair, being one of the most important components of the beauty care processes, attracts the use of a variety of hair treating cosmetics. Conventional hair treating cosmetics are not satisfactory for one reason or the other. Commercially used keratins are isolated from wool or chicken feathers. As these lack complete sequence identity with human hair keratin, are likely to be less efficient than the human hair keratin. K31, a type I acidic keratin, is a major protein of human hair keratin complex and it is essential for maintaining the hair tensile strength. In this study keratin K31 (46 kDa) gene was expressed in Escherichia coli at a level of approximately 35% of the total cell proteins. The protein, however, was expressed as insoluble inclusion bodies. The expressed protein was refolded and purified by FPLC using an anion-exchange column. The CD analysis results showed that the K31 was properly refolded. MALDI-TOF mass spectroscopy showed the characteristics expected for human K31 keratin. The refolded and partially purified K31 protein, when applied on chemically damaged hairs, increased the diameter of the hair up to 49%. The mechanical strength of the bleached hair increased by almost 2 fold after a single treatment of K31. The protein also straightened curly hair efficiently on a single treatment for one hour. Application of K31 resulted in marked improvements in smoothness, diameter and mechanical strength of the damaged hair.
1